Request an Appointment



Contact us with Questions

Expand Content

Tatiana Byzova, PhD


Tatiana Byzova, PhD
Department: Molecular Cardiology
Location: Cleveland Clinic Main Campus
Mail Code NB50
9500 Euclid Avenue
Cleveland, OH 44195
Tatiana Byzova, PhD
Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code NB50
9500 Euclid Avenue
Cleveland, OH 44195
Tatiana Byzova, PhD
Department: Lerner Research Institute
Director, Angiogenesis Research Center
Location: Cleveland Clinic Main Campus
Mail Code NB50
9500 Euclid Avenue
Cleveland, OH 44195
Adults Only

Biographical Sketch

Tatiana V. Byzova, PhD, is Associate Staff in Molecular Cardiology and Assistant Staff in the Taussig Cancer Institute at Cleveland Clinic.

Dr. Byzova earned her graduate degrees in cell biology and chemistry from Moscow State University in Russia in 1991. She completed a PhD cell biology at the National Cardiology Research Center, Moscow, Russia, in 1995. She was appointed to Cleveland Clinic in 1999.

Education & Fellowships

Doctorate - National Cardiology Center
Cell Biology
Moscow Russia
Graduate - Moscow State University

Specialty Interests

mechanisms of thrombosis, vascular pathophysiology, prostate cancer progression and metastasis, angiogenesis

Awards & Honors

Research funding from NIH

Innovations & Patents

Patent pending: "Novel approach to modulate angiogenesis," new technology to stimulate or inhibit neovascularization


  • American Heart Association
  • American Society of Hematology
  • American Association of Cancer Research

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/13/2015, Dr. Byzova has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Russian